For Black women in midlife
Health care being built for Black women in midlife, starting with fibroids
Today Ruby is free, cited guides and a free waitlist. Care programs open at launch, and Ruby launches care only under Black women clinical leadership.
What Ruby is today: free, cited guides and a free waitlist. Nothing is prescribed, nothing is sold, and no care is delivered yet. Programs open at launch, only under Black women clinical leadership.
The starting point
Being believed is the first treatment
You said the bleeding was heavy. They said that's normal. You said you hadn't slept in two years. They said that's normal. You said you'd gained forty pounds in eighteen months. They said eat less. None of that is normal.
Ruby starts with being believed, and then makes it useful. The guides on this site give you the published thresholds, the named tests, and the exact sentence to open your next appointment with, so what you feel becomes something a clinician acts on.
And Ruby starts with fibroids, because the brands built for midlife women mostly do not. Hormones and weight care are everywhere. The condition that shapes so many Black women's midlife years is not.
Over 80%
estimated cumulative incidence of uterine fibroids by age 50 for Black women, against nearly 70% for white women, in an ultrasound-screened cohort of 1,364 women.[1]
6.8x
the myomectomy rate for African American women relative to white women, alongside 3.5 times the hospitalization rate and 2.4 times the hysterectomy rate.[2]
10.1 years
median duration of frequent vasomotor symptoms for African American women in SWAN, against 6.5 years for non-Hispanic white women.[3]
73.4%
of 271,885 US inpatient fibroid procedures from 2016 to 2022 were hysterectomy. Embolization, the least invasive option on that list, was 3.5%.[4]
These are figures about how often something happens and how a system responds. They describe risk across a population. They are not a prediction about you, and no number here is a verdict on any one body.
The launch gate
Care launches only under Black women clinical leadership
That is a launch condition, not a slogan. Ruby will not deliver care, prescribe, or charge anyone until Black women clinicians hold founding equity and operational authority over clinical policy. Not advisory seats. The search is underway now.
Until each name is real, no name appears on this site. No team page, no borrowed bios, no stock faces.
Read this first
- In an emergency, call 911. In a mental health crisis, call or text 988, any hour.
- If you already have a clinician who believes you, keep them. Bring them the guides on this site if they help.
- Ruby is not an emergency service, not a pharmacy, and not live yet. Today this site is guides and a waitlist, nothing more.
Fibroids first, then the rest
What opens at launch
First, always
Fibroid symptom management
Care built around the bleeding, the iron loss, and the pressure symptoms, with referral coordination when a procedure conversation is due.
Core program
HRT
Hormone therapy in patch, oral, and topical forms, prescribed only where a clinician decides it fits, with the published cautions said out loud.
Add-on
Hair and scalp
Traction alopecia and CCCA care that starts with the follicle-sparing basics and is honest about what scarring means for regrowth.
Add-on
Sleep and mood
Non-controlled, first-line options only, attached to the rest of your care instead of split across three portals.
Weight care programs are planned too, and they live on the pricing page with everything else. Nothing on this site is a checkout.
Where we stand, plainly
What we will and won't claim
Medication manages symptoms
Medication for fibroids manages symptoms and, for some options, reduces size while treatment continues. It does not remove fibroids, and symptoms return after effective therapy stops.[5] Anyone promising otherwise is selling something.
No teas, no secret protocols
No herbal product, tea, cleansing regimen or special diet appears anywhere in the fibroid treatment options published by Cleveland Clinic or the Office on Women's Health.[6][7] Our guides will never sell you one.
Disagreement reported as disagreement
Cleveland Clinic puts the chance of a cancerous fibroid at 1 out of 350.[6] The Office on Women's Health says below one in 1,000.[7] Where published sources differ, Ruby shows both figures and names each source.
No invented anything
No made-up praise, no member counts, no stock faces, no names before they are real. Every number on this page carries a citation to a public source, listed at the bottom, each one checked live.
Sources cited on this page
- [1] Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM, High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence, American Journal of Obstetrics and Gynecology (2003), PubMed. https://pubmed.ncbi.nlm.nih.gov/12548202/. Accessed 2026-08-06.
- [2] Eltoukhi HM, Modi MN, Weston M, Armstrong AY, Stewart EA, The health disparities of uterine fibroid tumors for African American women, American Journal of Obstetrics and Gynecology (2013), PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC3874080/. Accessed 2026-08-06.
- [3] Avis NE, Crawford SL, Greendale G, et al., Duration of menopausal vasomotor symptoms over the menopause transition, JAMA Internal Medicine (2015), PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC4433164/. Accessed 2026-08-06.
- [4] Elhakim TS, et al., Disparities in utilization of uterine fibroid embolization, JAMA Network Open (2025), PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC12441870/. Accessed 2026-08-06.
- [5] Barseghyan M, Chae-Kim J, Catherino WH, The efficacy of medical management of leiomyoma-associated heavy menstrual bleeding, F&S Reports (2023), PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC10958631/. Accessed 2026-08-06.
- [6] Cleveland Clinic, Uterine fibroids. https://my.clevelandclinic.org/health/diseases/9130-uterine-fibroids. Accessed 2026-08-06.
- [7] Office on Women's Health, Uterine fibroids. https://womenshealth.gov/a-z-topics/uterine-fibroids. Accessed 2026-08-06.
Programs open at launch
The guides are free now. The care comes after the gate.
The waitlist is free and it is the only signup that exists. Care launches only under Black women clinical leadership, and until then the guides cite their sources and cost nothing.